Isopto

Pilocarpine Hydrochloride, the active ingredient in Isopto, is a cholinergic agonist presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with various forms of glaucoma and ocular hypertension.

GNH USA supplies Isopto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isopto is a cholinergic agonist used in the management of glaucoma‑related conditions, acting to improve aqueous outflow and reduce intra‑ocular pressure.

- Open‑angle glaucoma: helps lower intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: reduces elevated eye pressure in patients without optic nerve damage. - Acute angle‑closure glaucoma: induces rapid miosis to open the drainage angle and relieve pressure.

Pilocarpine eye drops may cause a range of ocular and systemic reactions. Patients should be informed of both frequent and less common events.

Common Side Effects: - Blurred vision: transient loss of visual clarity after instillation. - Eye irritation or burning: mild discomfort at the application site. - Headache: occasional mild headache following use. - Brow ache: discomfort around the eyebrow region. - Increased tearing: excess lacrimation after dosing. - Conjunctival hyperemia: redness of the eye.

Serious or Rare Side Effects: - Severe ocular inflammation: signs of uveitis or keratitis. - Allergic reaction: swelling, rash, or hives requiring medical attention. - Systemic cholinergic toxicity: nausea, vomiting, sweating, or bradycardia. - Persistent miosis: prolonged pupil constriction affecting vision. - Elevated intra‑ocular pressure paradoxically: rare worsening of pressure.

Before prescribing Isopto, clinicians should consider several safety aspects to minimize risk. - Hypersensitivity: avoid use in patients with known allergy to pilocarpine or formulation excipients. - Respiratory disease: use with caution in asthma or chronic obstructive pulmonary disease. - Cardiovascular conditions: monitor patients with bradycardia or conduction abnormalities. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Intra‑ocular pressure monitoring: assess pressure regularly to ensure therapeutic effect. - Store at room temperature: keep in original container, protect from light and moisture.

Pilocarpine may interact with other medications that influence cholinergic pathways or ocular physiology.

Major Interactions (Avoid): - Systemic cholinesterase inhibitors (e.g., neostigmine): additive cholinergic effects may cause toxicity. - Beta‑blocker eye drops: may blunt pilocarpine‑induced intra‑ocular pressure reduction.

Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., atropine, antihistamines): may reduce pilocarpine efficacy. - MAO inhibitors: potential for enhanced autonomic effects. - Topical steroids: may increase risk of ocular hypertension when combined.